Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07610226 · ClinicalTrials.gov registry record
Post-refractive IOL Outcomes With Clareon TruPlus
A clinical trial, sponsored by Laser Defined Vision.
- Recruiting
- Registry status
- 35
- Enrollment target
NCT07610226 is a clinical trial that is actively recruiting participants, run by Laser Defined Vision. The registered enrollment target is 35 participants.
The verdict
NCT07610226 is actively recruiting participants, sponsored by Laser Defined Vision.
- RECRUITING
- Registry status
- 35 participants
- Enrollment target
Study Summary
This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.
Interventions
- DEVICE Clareon TruPlus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2027-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07610226
The ClinicalTrials.gov registry entry for NCT07610226 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laser Defined Vision, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clareon TruPlus is the first listed.
NCT07610226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07610226 about?
NCT07610226 is a clinical study titled "Post-refractive IOL Outcomes With Clareon TruPlus". This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the P...
What is the current status of trial NCT07610226?
This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2026-06-23. Estimated completion is 2027-06-23.
What interventions are being tested in trial NCT07610226?
The interventions under investigation include: Clareon TruPlus (DEVICE).
Who is sponsoring clinical trial NCT07610226?
This trial is sponsored by Laser Defined Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.